A CATCH-UP programme for the chickenpox vaccine has been added into the routine childhood vaccination programme in the North.
The varicella (chickenpox) vaccine was added to the programme in January, and now the Public Health Agency (PHA) is urging parents of eligible older children who have not yet had chickenpox, or two doses of the varicella vaccination, to get vaccinated as a selective catch-up programme gets under way.
All children born on or after 1 September 2022 are eligible to receive it.
The catch-up programme, which is running until March 31 2028 will also enable children born between 1 January 2020 and 31 August 2022 to receive a single dose of MMRV (measles, mumps, rubella and varicella) vaccine.

This is to help protect them against chickenpox if they have not had the infection before, or they have not already been vaccinated against chickenpox.
Louise Flanagan, PHA consultant said: “Chickenpox is often seen as a common and mild illness, but for some babies, young children and even adults, chickenpox can be very serious, leading to hospital admission and in some cases can be fatal.
“In January 2026, the MMRV vaccine replaced the MMR in the routine immunisation schedule to help protect children from measles, mumps, rubella, and varicella, also known as chickenpox.
“Children were previously offered two MMR vaccines when they were aged 12 months and at three years and four months old.”
She added: “Although the MMRV vaccine is now offered to all young children, this catch-up will enable those who were just above the age threshold for this and therefore will not have received vaccine protection against chickenpox but may still be exposed to it in a range of settings.
“By offering this single dose of MMRV, we can help protect these children against chickenpox – not just the characteristic spots and general unwellness associated with the illness, but also the serious complications that can develop from it such as bacterial infection of skin lesions and, in rare cases, swelling of the brain, lung infection and stroke.
“The vaccine will also help reduce the number of days off from school, and time parents have to take off work, as a result of this highly-transmissible disease.”
Evidence from its use in other countries shows that the vaccine has a good safety record and is very effective.
One dose of MMRV is more than 90 per cent effective at protecting against any chickenpox infection, and around 99 per cent effective at protecting against a severe chickenpox infection.
A child’s red book will have all the vaccines received so far or a health visitor or GP surgery will be able to help.
For more information visit www.nidirect.gov.uk/childhood-immunisation



